The absolute bioavailability of caffeine in man

Aldridge A, Parsons WD, Neims AH (1977) Stimulation of caffeine metabolism in the rat by 3-methylcholanthrene. Life Sci 21: 967?974

Aranda JV, Cook CE, Gorman W, Collinge JM, Loughnan PM, Outerbridge EW, Aldridge A, Neims AH (1979) Pharmacokinetic profile of caffeine in the premature newborn infant with apnea. J Pediatr 94: 663?668

Aranda JV, Gorman W, Bergsteinsson H, Gunn T (1977) Efficacy of caffeine in treatment of apnea in the low-birth-weight infant. J Pediatr 90: 467?472

Axelrod J, Reichenthal J (1953) The fate of caffeine in man and a method for its estimation in biological material. J Pharmacol Exp Ther 107: 519?523

Bada HS, Khanna NN, Somani SM, Tin AA (1979) Interconversion of theophylline and caffeine in newborn infants. J Pediatr 94: 993?995

Blanchard J, Mohammadi JD, Conrad KA (1980) Improved liquid-chromatographic determination of caffeine in plasma. Clin Chem 26: 1351?1354

Blanchard J, Mohammadi JD, Trang JM (1981) Elimination of a potential interference in assay for plasma caffeine. Clin Chem 27: 637?639

Boxenbaum HG, Riegelman S, Elashoff RM (1974) Statistical estimations in pharmacokinetics. J Pharmacokin Biopharm 2: 123?148

Chiou WL, Lui CY, Lam G (1981) Plasma area method in relative bioavailability evaluation of drugs with changing biological half-lives. J Pharm Sci 70: 109?112

Koup JR, Gibaldi M (1980) Some comments on the evaluation of bioavailability data. Drug Intell Clin Pharm 14: 327?330

Nelder JA, Mead R (1965) A simplex method for function minimization. Comput J 7: 308?313

Ottaway JH (1973) Normalization in the fitting of data by iterative methods. Biochem J 134: 729?736

Riggs DS (1963) The mathematical approach to physiological problems. Williams and Wilkins, Baltimore, MD, p 51

Rowland M (1980) Intra-individual variability in pharmacokinetics. In: Breimer DD (ed) Towards better safety of drugs and pharmaceutical products. Elsevier/North-Holland Biomedical Press, New York, pp 143?151

Tozer TN (1979) Pharmacokinetic principles relevant to bioavailability studies. In: Blanchard J, Sawchuk RJ, Brodie BB (eds) Principles and perspectives in drug bioavailability. Karger, Basel, pp 120?155

Upton RA, Riegelman S, Sheiner LB (1980) Bioavailability assessment as influenced by changes in drug disposition. In: Albert KS (ed) Drug absorption and disposition: statistical considerations. Am Pharm Assoc, Washington, DC, pp 77?86